home / stock / fldm / fldm quote
Last: | $3.71 |
---|---|
Change Percent: | -7.02% |
Open: | $4.05 |
Close: | $3.71 |
High: | $4.05 |
Low: | $3.66 |
Volume: | 526,846 |
Last Trade Date Time: | 04/05/2022 04:54:08 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.71 | $4.05 | $3.71 | $4.05 | $3.66 | 526,846 | 04-05-2022 |
$3.99 | $3.79 | $3.99 | $4.19 | $3.75 | 625,839 | 04-04-2022 |
$3.77 | $3.61 | $3.77 | $3.79 | $3.5 | 525,503 | 04-01-2022 |
$3.59 | $3.86 | $3.59 | $3.86 | $3.58 | 453,146 | 03-31-2022 |
$3.78 | $3.96 | $3.78 | $4.03 | $3.77 | 406,312 | 03-30-2022 |
$3.96 | $3.6 | $3.96 | $3.995 | $3.6 | 643,833 | 03-29-2022 |
$3.58 | $3.56 | $3.58 | $3.705 | $3.44 | 467,157 | 03-28-2022 |
$3.52 | $3.77 | $3.52 | $3.77 | $3.43 | 529,139 | 03-25-2022 |
$3.76 | $3.93 | $3.76 | $3.93 | $3.73 | 327,589 | 03-24-2022 |
$3.92 | $3.9 | $3.92 | $3.97 | $3.735 | 650,442 | 03-23-2022 |
$3.9 | $3.7 | $3.9 | $3.92 | $3.685 | 525,362 | 03-22-2022 |
$3.67 | $3.77 | $3.67 | $3.81 | $3.62 | 297,690 | 03-21-2022 |
$3.79 | $3.69 | $3.79 | $4 | $3.6 | 663,127 | 03-18-2022 |
$3.73 | $3.49 | $3.73 | $3.78 | $3.46 | 365,968 | 03-17-2022 |
$3.57 | $3.38 | $3.57 | $3.59 | $3.36 | 480,213 | 03-16-2022 |
$3.35 | $3.33 | $3.35 | $3.375 | $3.25 | 884,775 | 03-15-2022 |
$3.27 | $3.42 | $3.27 | $3.46 | $3.23 | 1,465,508 | 03-14-2022 |
$3.4 | $3.66 | $3.4 | $3.66 | $3.4 | 290,669 | 03-11-2022 |
$3.63 | $3.57 | $3.63 | $3.665 | $3.45 | 330,830 | 03-10-2022 |
$3.69 | $3.49 | $3.69 | $3.79 | $3.47 | 402,851 | 03-09-2022 |
News, Short Squeeze, Breakout and More Instantly...
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLO...
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the m...
SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced the introduction of new solutions that add automation and flexibilit...